Enhanced ECE activity leads to increased ET-1 levels, which, as a potent vasoconstrictor involved in neuroinflammation, can aggravate neuronal damage and promote the progression of neurodegenerative diseases. Here, EDN1 is linked to neurodegenerative disease.